Leverkusen, Germany, July 06, 2021 (GLOBE NEWSWIRE) — Biofrontera AG at the moment holds 100 % of the shares of the US-based Biofrontera Inc.
Biofrontera AG had already introduced that alternatives for capital raises have been being evaluated together with a possible preliminary public providing (“IPO”) of Biofrontera Inc. in america.
The primary targets of an IPO of Biofrontera Inc. could be to boost extra capital to fund its development of operations, to create a public marketplace for its shares and to facilitate future entry to the capital market.
A registration assertion regarding the securities to be provided within the IPO has been filed with the Securities and Change Fee however has not but change into efficient. These securities will not be bought nor might presents to purchase these securities be accepted previous to the time the registration assertion turns into efficient. This press launch shall not represent a proposal to promote or the solicitation of a proposal to purchase nor shall there be any sale of those securities in any state or jurisdiction through which such supply, solicitation or sale could be illegal previous to registration or qualification below the securities legal guidelines of any such state or jurisdiction.
Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
Tel: +49 (0214) 87 63 2 0, Fax: +49 (0214) 87 63 290
E mail: email@example.com
Ahead-Trying Statements: Sure statements on this press launch are forward-looking throughout the that means of the Personal Securities Litigation Reform Act of 1995 relating to the general public providing and the meant use of proceeds from the providing.
These statements could also be recognized by way of forward-looking phrases reminiscent of “anticipate,” “imagine,” “forecast,” “estimate” and “intend,” amongst others. Such forward-looking statements are based mostly on the at the moment held beliefs and assumptions of the administration of Biofrontera AG, that are expressed in good religion and, of their opinion, affordable. Ahead-looking statements contain identified and unknown dangers, uncertainties and different elements, which can trigger the precise outcomes, monetary situation, efficiency, or achievements of the Firm, or trade outcomes, to vary materially from the outcomes, monetary situation, efficiency or achievements expressed or implied by such forward-looking statements. These dangers, uncertainties and different elements are set forth within the annual report on Kind 20-F filed with the SEC, together with Merchandise 3.D. “Key Info – Danger Components,” and in future studies filed with the SEC. Given these dangers, uncertainties and different elements, potential buyers are cautioned to not place undue reliance on these forward-looking statements. The Firm doesn’t undertake an obligation to replace or revise any forward-looking assertion.